BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38069178)

  • 1. Dietary Potassium Supplementation Reduces Chronic Kidney Lesions Independent of Blood Pressure in Deoxycorticosterone-Acetate and High Sodium Chloride-Treated Mice.
    Wang Q; Schäfer SC; Haefliger JA; Maillard MP; Alonso F
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potassium supplementation reduces cardiac and renal hypertrophy independent of blood pressure in DOCA/salt mice.
    Wang Q; Domenighetti AA; Pedrazzini T; Burnier M
    Hypertension; 2005 Sep; 46(3):547-54. PubMed ID: 16103267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension.
    Krishnan SM; Ling YH; Huuskes BM; Ferens DM; Saini N; Chan CT; Diep H; Kett MM; Samuel CS; Kemp-Harper BK; Robertson AAB; Cooper MA; Peter K; Latz E; Mansell AS; Sobey CG; Drummond GR; Vinh A
    Cardiovasc Res; 2019 Mar; 115(4):776-787. PubMed ID: 30357309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Necrosis Factor Alpha Deficiency Improves Endothelial Function and Cardiovascular Injury in Deoxycorticosterone Acetate/Salt-Hypertensive Mice.
    Cai R; Hao Y; Liu YY; Huang L; Yao Y; Zhou MS
    Biomed Res Int; 2020; 2020():3921074. PubMed ID: 32190663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anakinra reduces blood pressure and renal fibrosis in one kidney/DOCA/salt-induced hypertension.
    Ling YH; Krishnan SM; Chan CT; Diep H; Ferens D; Chin-Dusting J; Kemp-Harper BK; Samuel CS; Hewitson TD; Latz E; Mansell A; Sobey CG; Drummond GR
    Pharmacol Res; 2017 Feb; 116():77-86. PubMed ID: 27986554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Triad Na
    Gonsalez SR; Gomes DS; de Souza AM; Ferrão FM; Vallotton Z; Gogulamudi VR; Lowe J; Casarini DE; Prieto MC; Lara LS
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal Medullary Overexpression of Sphingosine-1-Phosphate Receptor 1 Transgene Attenuates Deoxycorticosterone Acetate (DOCA)-Salt Hypertension.
    Hu G; Xie D; Chen C; Wang W; Li PL; Ritter JK; Li N
    Am J Hypertens; 2023 Aug; 36(9):509-516. PubMed ID: 37171128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of TRPV4 by dietary apigenin antagonizes renal fibrosis in deoxycorticosterone acetate (DOCA)-salt-induced hypertension.
    Wei X; Gao P; Pu Y; Li Q; Yang T; Zhang H; Xiong S; Cui Y; Li L; Ma X; Liu D; Zhu Z
    Clin Sci (Lond); 2017 Apr; 131(7):567-581. PubMed ID: 28143892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of CXCR6 Ameliorates Kidney Inflammation and Fibrosis in Deoxycorticosterone Acetate/Salt Hypertension.
    Wu Y; An C; Jin X; Hu Z; Wang Y
    Sci Rep; 2020 Jan; 10(1):133. PubMed ID: 31924817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon regulatory factor 4 deletion protects against kidney inflammation and fibrosis in deoxycorticosterone acetate/salt hypertension.
    Gao Y; Liu B; Guo X; Nie J; Zou H; Wen S; Yu W; Liang H
    J Hypertens; 2023 May; 41(5):794-810. PubMed ID: 36883469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal protective effects of N-acetyl-Ser-Asp-Lys-Pro in deoxycorticosterone acetate-salt hypertensive mice.
    Rhaleb NE; Pokharel S; Sharma U; Carretero OA
    J Hypertens; 2011 Feb; 29(2):330-8. PubMed ID: 21052020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium butyrate ameliorates deoxycorticosterone acetate/salt-induced hypertension and renal damage by inhibiting the MR/SGK1 pathway.
    Wu C; Chen Z; Zhang L; Zhu Y; Deng M; Huang C; Liu Y; Zhu Q; Wang L
    Hypertens Res; 2021 Feb; 44(2):168-178. PubMed ID: 32908237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renoprotective effect of rosuvastatin in DOCA-salt hypertensive rats.
    Bae EH; Kim IJ; Park JW; Ma SK; Lee JU; Kim SW
    Nephrol Dial Transplant; 2010 Apr; 25(4):1051-9. PubMed ID: 19948880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of TRPV1 against renal fibrosis via inhibition of TGF-β/Smad signaling in DOCA-salt hypertension.
    Wang Y; Wang DH
    Mol Med; 2011; 17(11-12):1204-12. PubMed ID: 21792478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension.
    Wang Y; Wang DH
    Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1550-9. PubMed ID: 19794112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of angiotensin-converting enzyme inhibitor and angiotensin type 1 receptor antagonist in deoxycorticosterone acetate-salt hypertensive mice lacking Ren-2 gene.
    Peng H; Carretero OA; Alfie ME; Masura JA; Rhaleb NE
    Hypertension; 2001 Mar; 37(3):974-80. PubMed ID: 11244026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CS-3150, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, Shows Preventive and Therapeutic Effects On Renal Injury in Deoxycorticosterone Acetate/Salt-Induced Hypertensive Rats.
    Arai K; Morikawa Y; Ubukata N; Tsuruoka H; Homma T
    J Pharmacol Exp Ther; 2016 Sep; 358(3):548-57. PubMed ID: 27384074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 1B1 gene disruption minimizes deoxycorticosterone acetate-salt-induced hypertension and associated cardiac dysfunction and renal damage in mice.
    Jennings BL; Estes AM; Anderson LJ; Fang XR; Yaghini FA; Fan Z; Gonzalez FJ; Campbell WB; Malik KU
    Hypertension; 2012 Dec; 60(6):1510-6. PubMed ID: 23108654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mononuclear phagocyte system depletion blocks interstitial tonicity-responsive enhancer binding protein/vascular endothelial growth factor C expression and induces salt-sensitive hypertension in rats.
    Machnik A; Dahlmann A; Kopp C; Goss J; Wagner H; van Rooijen N; Eckardt KU; Müller DN; Park JK; Luft FC; Kerjaschki D; Titze J
    Hypertension; 2010 Mar; 55(3):755-61. PubMed ID: 20142563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
    Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T
    Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.